Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Stroke. 2012 May 8;43(7):1925–1930. doi: 10.1161/STROKEAHA.111.647982

Figure 4.

Figure 4

Bevacizumab treatment increased TUNEL-positive cells on vessel wall. (A) Representative images show sections double stained with lectin (green, left), TUNEL (brown, middle), and merged (right). The bevacizumab treated group had more TUNEL-positive vascular cells (arrows) as compared to trastuzumab. A few TUNEL-positive cells were not associated with a vessel (arrowheads). Insets are high magnification images showing TUNEL-positive nuclei co-localized with lectin. Scale bar: 50 μm. (B) Bar graph shows quantification of TUNEL-positive vascular cells (*p=0.03).